Assoc. Prof & Research Director, Pharmacology Dept, NUS; PI @ CSI_Singapore; Interest: Tomorrow's tech that improves cancer treatment today
Singapore
Joined April 2009
- Tweets16
- Following82
- Followers115
- Likes254
Edward Chow retweeted
Is #personalization of drug combinations possible/ feasible in cancer care? Check out our latest publication in @ScienceTM: science.org/doi/10.1126/scit…. Fantastic collaboration with @echow310 and clinical/ scientific colleagues @NUSMedicine @SingHealthSG @csi_singapore 1/n
Edward Chow retweeted
Really chuffed to have our work accepted as an oral presentation at #ASH2021 ash.confex.com/ash/2021/webp…
We report our clinical experience with #personalized combination treatments in relapsed #lymphoma - a fantastic collaboration with @echow310 and colleagues across Singapore.
Edward Chow retweeted
Hilarious. Cambridge flashbacks @rsyf2?
This Post is from an account that no longer exists. Learn more
Edward Chow retweeted
DEADLINE EXTENDED! The closing date for abstract submission has been extended to 11 January 2021. Submit your abstracts today: csi.nus.edu.sg/web/epigeneti…
Do not miss the opportunity to present your research at the Epigenetics in Cancer Symposium 2021! Abstract submission closes on 28 December. Submit your abstract today! csi.nus.edu.sg/web/epigeneti…
Edward Chow retweeted
Our bond free premium scholarship provides you with the opportunity to work with a dynamic team of renowned scientists in an intellectually stimulating environment. Apply for the CSI PhD Graduate Program now! csi.nus.edu.sg/web/graduate-…
Edward Chow retweeted
Do not miss the opportunity to present your research at the Epigenetics in Cancer Symposium 2021! Abstract submission closes on 28 December. Submit your abstract today! csi.nus.edu.sg/web/epigeneti…
Abstract submission is now OPEN for the Epigenetics in Cancer Symposium 2021! Find out more here: rb.gy/hkutsw Register today at: rb.gy/9bhdij
Edward Chow retweeted
It was a privilege working with an amazing team on this paper @TrendsinBiotech! @WeAreWisDM @TheN1Institute @BME_NUS @chngwj @PersonalizedMed @The__Liver @echow310 – at West Region, Singapore
Enabling Technologies for Personalized and Precision Medicine #artificialintelligence @TrendsinBiotech @thedeanh @TheN1Institute @BME_NUS hubs.ly/H0zwVyr0
Edward Chow retweeted
Abstract submission is now OPEN for the Epigenetics in Cancer Symposium 2021! Find out more here: rb.gy/hkutsw Register today at: rb.gy/9bhdij
Edward Chow retweeted
The Epigenetics in Cancer Symposium (15-17 Feb 2021) is a high profile conference with a lineup of internationally distinguished speakers. Registration is now open: cutt.ly/2hqOAIR More info available here: cutt.ly/LhqOPl3 @denniskappei @DefossezPierre
Edward Chow retweeted
ICYMI: The NADIM study: #Neoadjuvant #chemotherapy and #nivolumab in resectable non-small-cell #lungcancer: an open-label, multicentre, single-arm, phase 2 trial
#NSCLC #lcsm thelancet.com/journals/lanon…
Edward Chow retweeted
Check out our recent paper in Adv. Mat. on non-genetic modifications of cells by depositing nano-complexes of biomomecules on cell surfaces. Anti-PDL1 nano-complexes on macrophages markedly improved tumor response in mice doi.org/10.1002/adma.2020034… @wyssinstitute @hseas
Edward Chow retweeted
Free registration is open for the virtual @CSI_Singapore Frontiers in Cancer Science Annual Conference, Nov 2-6. We are partnering with FCS to organize three AACR-FCS Education Sessions for graduate students and early-career investigators. Learn more:
nus.edu/2HJMeBq
